Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity

Matrix metalloproteinases: structures, evolution, and diversification

Irina Massova, Lakshmi P. Kotra, Rafael Fridman et al. · The FASEB Journal · 1998 · 773 citations

Comprehensive Sequence Alignment, Biochemistry, Protein Folding +14

Identification of functional angiotensin II receptors on rat cardiac fibroblasts.

Francisco Villarreal, N N Kim, GilAnthony Ungab et al. · Circulation · 1993 · 367 citations

Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR

Philip J. Hajduk, George S. Sheppard, David G. Nettesheim et al. · Journal of the American Chemical Society · 1997 · 316 citations

Design of iron chelators with therapeutic application

Zu D. Liu, Robert C. Hider · Coordination Chemistry Reviews · 2002 · 285 citations

Iron Chelators, Inorganic Synthesis, Chemistry

New Beginnings for Matrix Metalloproteinase Inhibitors:  Identification of High-Affinity Zinc-Binding Groups

D.T. Puerta, Jana A. Lewis, Seth M. Cohen · Journal of the American Chemical Society · 2004 · 143 citations

Inhibitory Activity, Medicinal Chemistry, New Zbgs +13